InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Strobeck Matthew, Director. Director active across 4 companies, notably QUIDEL CORP. In total, 11 reports have been recorded. Total volume traded: €2m. The latest transaction was filed on 18 May 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
6,533 shares
Common Stock
SEC:0000899243-22-020410:0·
6,533 shares
Common Stock
SEC:0000899243-22-020490:0·
01,624 shares0
Common Stock
SEC:0001209191-22-031194:0·
€920,400558,659 shares@ €1.64751.70% mcap46.4% of flow
Common Stock
SEC:0001567619-22-008353:0·
Ideal exit: 2 Jan 2023 (T+270)
20,044 shares
Common Stock
SEC:0001140361-22-012920:0·
€531,107138,700 shares@ €3.82920.98% mcap100.0% of flow
Common Stock
SEC:0001567619-22-000277·
Ideal exit: 26 Sept 2022 (T+270)
€531,107138,700 shares@ €3.82920.98% mcap26.8% of flow
Common Stock
SEC:0001567619-22-000277:0·
Ideal exit: 26 Sept 2022 (T+270)
€129,59419,531 shares@ €6.6353100.0% of flow
Common Stock
SEC:0001628280-21-024840·
€129,59419,531 shares@ €6.635350.0% of flow
Common Stock
SEC:0001628280-21-024840:0·
01,040 shares0
Common Stock
SEC:0001209191-21-032981·
01,040 shares0
Common Stock
SEC:0001209191-21-032981:0·
11 of 11 declarations
About Strobeck Matthew
Matthew Strobeck serves as a Board Member at Quidel Corp, Accelerate Diagnostics, Inc, and Biodesix Inc. As a board member, he plays a key role in the governance and strategy of the companies. His expertise is essential for their development.
